Get started
Moderna, Inc.Moderna, Inc.Moderna, Inc.

Moderna, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

MRNA trade ideas

Moderna - Short it into the Ground Never have I used this platform to message outside of what I believed Future contract or stock could do in the future. Till now. There is a trade here too. The tweet is from Robert F. Kennedy Jr. - confidant sure you recognize the name hence why I choose this one. (Although there are 100's) Nice video explaining what's going on, and what the plan is going forward. Just in case you are not aware. $PFE and $MRNA use the same tech to modify Human RNA (ribonucleic acid.) They're clinical trials are marred in fraud, they have made billions, and would be exempt from litigation except they lied about the safety of their products. Why short Moderna instead of Pfizer? Pfizer has full pipeline of drugs, Moderna does not. TRADE: We're just about at the .78 Fib retracement -which is a nice entry location. The $165 - 166 area. One hour chart, clear double top forming and the RSI is weaker. Green arrow points recent average price. This is the first target at $147. However when the MSM finally picks up this, they'll have NO choice, this stock potentially could trade into the single digits, but of course this will take more time. The last couple of days average volume has increased by almost 100%. One of the reasons that $PFE and $MRNA have run up is the expectation that current out break in China will call for more of these drugs. The counter argument to that is that Chinese will not engage the Americans directly about the war in Ukraine but are using this 'Outbreak' to disrupt supply chains further in the US. Think about it - outbreak, of what Omnicron? Because this trade setup is fairly obviously there is a chance that price may go higher to pull shorts before returning lower - so be careful. Its not implausible that we go all the way up to about $180 which would be 100% retracement on weekly Fib before heading back down.
NASDAQ:MRNAShort
by Maximilianned
2
An aggressive short: Moderna.Moderna is the example of a small company that has its entire wealth built around one thing: mRNA COVID vaccines. Before COVID, this company was moribund. As COVID vaccines reveal themselves to be much less efficacious that initially marketed and as Moderna vaccines are said to induce pretty severe side effects notably (see recommendations against it for young males in Europe), I see a potential aggressive short in this stock for 2022. They have a great ally though, and it's one of their patent holder: Anthony Fauci. But Fauci might become a handicap in the future for his potential role into gain of function research in China, his lies to Congress and his conflict of interests that absolutely no one can ignore. His fall into total disgrace might just be a matter of time (hopefully) and might drag Moderna with it. I could see the CEO progressively trying to exit. The dominoes might fall very quickly if it happens. On the other side, the risk to the upside still exist. Moderna might manage to push other types of vaccines (cancer? other illnesses?) after its success in the COVID vaccines industry. Fauci might also manage to drag his possible prosecutions and remember, he has powerful allies himself. Pfizer is another element to take into account. Moderna's main rival has a potential safe exit: their treatment named Paxlovid. Once Paxlovid is confirmed to be able to flood the world with a high price tag, Pfizer might not see the current vaccine propaganda to be as useful. In any way, be careful out there! 2022 might shake things out!
CAPITALCOM:MRNAShort
by romjpn
MRNA 3/14/2022MRNA If you didn’t catch the Covid hype train going up, you can catch it going down. MRNA’s uptrend found its top between Aug.’21 – Sept. 21 when the uptrend came to an end after closing below 50 ema which it was previously respecting to start trend. Price fell then started to move sideways between 227-362. On Dec. ’21 price attempted to make a move up but failed to make a higher high. Price was then knocked down to support @ 227. Price moves on to break down from support. Here we also witness a Death Cross with the 200 and 50 ema crossing further confirming the bearish conditions. Price has entered a downtrend. Price continued move down until it found support at 139. Price now finds itself in a descending triangle after making a series of higher lows into support of 139. This consolidation move in form of a descending triangle after start of downtrend can also be classified as a bear flag. (If you missed the initial leg of downtrend, this will give us chance to enter trade short). Currently, price has broken down from support area @ 139 and has pulled back to it in attempt to turn previous support into resistance. We have located a chart pattern in a downtrend. This pattern is currently making a series of lower highs into support. This is my cue to enter trade. Entering trade short. Entry: 138.20 Stop loss: 153.26 Target: 100.00- +27.64%, 2.54 RR ratio or will trade 10ema
NASDAQ:MRNAShort
by rudcharts
Moderna | MRNA | Short, Falling WedgeModerna ( NASDAQ:MRNA ) is in a falling wedge with no signs of escaping (yet). While it may have a small pop if there is good company news, the COVID-19 buying spree may be truly over. The COVID-19 pandemic will soon be an endemic and the market may shift fully away from "COVID-19 tickers". Insiders continue to dump shares. Since the start of 2022, insiders have sold $57 million worth of shares. $10 million of this total in the past 13 days (source: OpenInsider). I anticipate Moderna to be below $100 in the coming months if it doesn't break the falling wedge's resistance.
NASDAQ:MRNAShort
by WorthlessViews
Moderna USA Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's: SSITD & NexGen Portfolio of the Week Series Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
NASDAQ:MRNA
by Sunstorminvest
MRNA Mutli-week banger incomingMRNA buyers showed up last week with volume to the upside. There are a few options to play this to the upside or downside. Weekly 2Up: 180.8 2U continuation trigger with PTs to 186.8, 193.2, and 200.08. 4H Upside: This could be setting up for a 2-1-2 continuation to the upside plus the weekly 2U trigger. 4H Downside: I would look for a trigger below 173.83 followed with 2D continuation to take us closer to the weekly retest area at 160. Inverse Head and Shoulder/W/Cup and Handle (4H): A large cup appears to be forming since the beginning of Feb. If we get a pullback to the weekly retest area at 160, I would watch for a bullish reversal pattern and do a multi week swing up to the Jan retest zone around 200 and beyond.
NASDAQ:MRNA
by GammaRayGoated
Moderna: Sell the Break Setup Moderna - Short Term - We look to Sell a break of 137.05 (stop at 147.24) A move through bespoke support at 140.00 and we look for extended losses. Closed below the 20-day EMA. The primary trend remains bearish. Our overall sentiment remains bearish looking for lower levels. We look to set shorts in the early trade. Our profit targets will be 108.99 and 103.50 Resistance: 150.00 / 170.00 / 200.00 Support: 140.00 / 120.00 / 100.00 Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features. Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
NASDAQ:MRNAShort
by Saxo
2